{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:57:53Z","timestamp":1790744273913,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005712","name":"The University of Jordan","doi-asserted-by":"crossref","award":["2016"],"award-info":[{"award-number":["2016"]}],"id":[{"id":"10.13039\/501100005712","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005712","name":"The University of Jordan","doi-asserted-by":"crossref","award":["1731"],"award-info":[{"award-number":["1731"]}],"id":[{"id":"10.13039\/501100005712","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bmc.2019.05.038","type":"journal-article","created":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T22:41:49Z","timestamp":1559256109000},"page":"3005-3060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Fluoroquinolones structural and medicinal developments (2013\u20132018): Where are we now?"],"prefix":"10.1016","volume":"27","author":[{"given":"Ghadeer A.R.Y.","family":"Suaifan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya A.M.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2019.05.038_b0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/antibiotics6040026","article-title":"Ubiquitous nature of fluoroquinolones: the oscillation between antibacterial and anticancer activities","volume":"6","author":"Idowu","year":"2017","journal-title":"Antibiot."},{"key":"10.1016\/j.bmc.2019.05.038_b0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/ijms20020268","article-title":"Ciprofloxacin enhances the chemosensitivity of cancer cells to ABCB1 substrates","volume":"20","author":"Gupta","year":"2019","journal-title":"Inter J Mol Sci."},{"key":"10.1016\/j.bmc.2019.05.038_b0015","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejmech.2013.08.040","article-title":"Abuo-Rahma GE-DA, Sayed MA, Kwon Y, Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity","volume":"69","author":"Abdel-Aziz","year":"2013","journal-title":"Euro J Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0020","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1128\/AAC.00414-06","article-title":"Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy","volume":"51","author":"Shandil","year":"2007","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.bmc.2019.05.038_b0025","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1128\/AAC.49.8.3178-3181.2005","article-title":"Pharmacodynamic evidence that ciprofloxacin failure against tuberculosis is not due to poor microbial kill but to rapid emergence of resistance","volume":"49","author":"Gumbo","year":"2005","journal-title":"Antimicrobial Antimicrob Agents Chemother."},{"key":"10.1016\/j.bmc.2019.05.038_b0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.18433\/J3302N","article-title":"Nonclassical biological activities of quinolone derivatives","volume":"15","author":"Daneshtalab","year":"2011","journal-title":"J Pharm Pharm Sci."},{"key":"10.1016\/j.bmc.2019.05.038_b0035","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jmgm.2013.07.004","article-title":"Structural requirements of 3-carboxyl-4 (1H)-quinolones as potential antimalarials from 2D and 3D QSAR analysis","volume":"44","author":"Li","year":"2013","journal-title":"J Mol Graph Model."},{"key":"10.1016\/j.bmc.2019.05.038_b0040","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.bmc.2014.02.046","article-title":"Quinolone\u2013benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer Disease","volume":"22","author":"Pudlo","year":"2014","journal-title":"Bioorg Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0045","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bmcl.2016.11.084","article-title":"Recent advancements in the development of anti-tuberculosis drugs","volume":"27","author":"Chetty","year":"2017","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bmc.2019.05.038_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jctube.2016.12.001","article-title":"Impact of fluoroquinolone treatment on delay of tuberculosis diagnosis: a systematic review and meta-analysis","volume":"6","author":"Hogan","year":"2017","journal-title":"J Clin Tuberc Other Mycobact Dis."},{"key":"10.1016\/j.bmc.2019.05.038_b0055","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1073\/pnas.86.8.2809","article-title":"Fluorinated 4- quinolones induce hyper production of IL-2","volume":"86","author":"Riesbeck","year":"1989","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2019.05.038_b0060","doi-asserted-by":"crossref","first-page":"1288e1294","DOI":"10.1016\/S0022-5347(05)65283-4","article-title":"Role of mitochondria in ciprofloxacin induced apoptosis in bladder cancer cells","volume":"167","author":"Aranha","year":"2002","journal-title":"J Urol."},{"key":"10.1016\/j.bmc.2019.05.038_b0065","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1086\/428051","article-title":"The quinolones: past, present, and future","volume":"41","author":"Andriole","year":"2005","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.bmc.2019.05.038_b0070","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.bmcl.2018.03.085","article-title":"Design, synthesis, and evaluation of novel N-1 fluoroquinolone derivatives: probing for binding contact with the active site tyrosine of gyrase","volume":"28","author":"Towle","year":"2018","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bmc.2019.05.038_b0075","article-title":"Antibacterial Derivatives of Ciprofloxacin to Inhibit Growth of Necrotizing Fasciitis Associated Penicillin Resistant Escherichia coli","author":"Bartzatt","year":"2013","journal-title":"J Pharm."},{"key":"10.1016\/j.bmc.2019.05.038_b0080","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jac\/dkf501","article-title":"New strategies to overcome antimicrobial resistance in Streptococcus pneumoniae with \u03b2-lactam antibiotics","volume":"50","author":"Aguilar","year":"2002","journal-title":"J Antimicrob Chemoth."},{"key":"10.1016\/j.bmc.2019.05.038_b0085","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00044-016-1544-8","article-title":"Design, synthesis and biological activity evaluation of novel pefloxacin derivatives as potential antibacterial agents","volume":"25","author":"Allaka","year":"2016","journal-title":"Med Chem Res."},{"key":"10.1016\/j.bmc.2019.05.038_b0090","doi-asserted-by":"crossref","first-page":"M741","DOI":"10.3390\/M741","article-title":"2-(6-Methoxynaphthalen-2-yl) propionic acid (1, 3-dimethylbutylidene) hydrazide","volume":"2011","author":"Mamatha","year":"2011","journal-title":"Molbank."},{"key":"10.1016\/j.bmc.2019.05.038_b0095","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3390\/12081910","article-title":"Biological activities of hydrazone derivatives","volume":"12","author":"Rollas","year":"2007","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2019.05.038_b0100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ddr.21508","article-title":"Okechukwu PNJDdr, Design, synthesis, and biological evaluation of 1, 8-naphthyridine glucosamine conjugates as antimicrobial agents","volume":"80","author":"Mohammed","year":"2018","journal-title":"Drug Dev Res."},{"key":"10.1016\/j.bmc.2019.05.038_b0105","doi-asserted-by":"crossref","first-page":"6822","DOI":"10.3390\/molecules19056822","article-title":"Synthesis and antibacterial activity of amino acid and dipeptide prodrugs of IMB-070593, a fluoroquinolone candidate","volume":"19","author":"Zhang","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2019.05.038_b0110","first-page":"20","article-title":"Application of 7-(4-alkoxyimino-3-aminopiperidin-1-yl) fluoroquinolones and their combinations","volume":"101863876","author":"Gui","year":"2010","journal-title":"CN Patent"},{"key":"10.1016\/j.bmc.2019.05.038_b0115","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1007\/s00044-013-0873-0","article-title":"New azetidine-3-carbonyl-N-methyl-hydrazino derivatives of fluoroquinolones: synthesis and evaluation of antibacterial and anticancer properties","volume":"23","author":"Rajulu","year":"2014","journal-title":"Med Chem Res."},{"key":"10.1016\/j.bmc.2019.05.038_b0120","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1248\/cpb.56.346","article-title":"Synthesis of new quinolone antibiotics utilizing azetidine derivatives obtained from 1-azabicyclo [1.1. 0] butane","volume":"56","author":"Ikee","year":"2008","journal-title":"Chem Pharm Bull."},{"key":"10.1016\/j.bmc.2019.05.038_b0125","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2174\/156802607780090993","article-title":"Azetidine-based inhibitors of dipeptidyl peptidase IV (DPP IV)","volume":"7","author":"Ferraris","year":"2007","journal-title":"Curr Top Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000456533","article-title":"In vitro antibacterial activity of 7-substituted-6-fluoroquinolone and 7-substituted-6, 8-difluoroquinolone derivatives","volume":"62","author":"Leyva-Ramos","year":"2017","journal-title":"Chemotherapy."},{"key":"10.1016\/j.bmc.2019.05.038_b0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jfluchem.2018.01.007","article-title":"Synthesis and antimycobacterial evaluation of new (2-oxo-2H-chromen-3-yl) substituted fluoroquinolones","volume":"208","author":"Charushin","year":"2018","journal-title":"J Fluor Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0140","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ejmech.2014.09.029","article-title":"Synthesis, antimycobacterial and antibacterial evaluation of l-[(1R, 2S)-2-fluorocyclopropyl] fluoroquinolone derivatives containing an oxime functional moiety","volume":"86","author":"Liu","year":"2014","journal-title":"Euro J Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejmech.2015.09.030","article-title":"Synthesis, antimycobacterial and antibacterial activity of fluoroquinolone derivatives containing an 3-alkoxyimino-4-(cyclopropylanimo) methylpyrrolidine moiety","volume":"104","author":"Zhang","year":"2015","journal-title":"Euro J Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0150","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1021\/jm701428b","article-title":"Synthesis and antibacterial activity of novel pyrido [1, 2, 3-de][1, 4] benzoxazine-6-carboxylic acid derivatives carrying the 3-cyclopropylaminomethyl-4-substituted-1-pyrrolidinyl group as a C-10 substituent","volume":"51","author":"Asahina","year":"2008","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0155","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.bmcl.2016.03.050","article-title":"Synthesis, antimycobacterial and antibacterial activity of 1-(6-amino-3, 5-difluoropyridin-2-yl) fluoroquinolone derivatives containing an oxime functional moiety","volume":"26","author":"Huang","year":"2016","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bmc.2019.05.038_b0160","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.bmcl.2006.02.065","article-title":"Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase","volume":"16","author":"Sriram","year":"2006","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bmc.2019.05.038_b0165","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1039\/C7CC09518J","article-title":"Developing ciprofloxacin analogues against plant DNA gyrase: a novel herbicide mode of action","volume":"54","author":"Wallace","year":"2018","journal-title":"Chem Commun."},{"key":"10.1016\/j.bmc.2019.05.038_b0170","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ps.1518","article-title":"Glyphosate: a once-in-a-century herbicide","volume":"64","author":"Duke","year":"2008","journal-title":"Pest Manag Sci."},{"key":"10.1016\/j.bmc.2019.05.038_b0175","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1248\/cpb.c13-00797","article-title":"New hydroxamic acid derivatives of fluoroquinolones: synthesis and evaluation of antibacterial and anticancer properties","volume":"62","author":"Rajulu","year":"2014","journal-title":"Chem Pharm Bull."},{"key":"10.1016\/j.bmc.2019.05.038_b0180","doi-asserted-by":"crossref","first-page":"8441","DOI":"10.1021\/acs.jmedchem.6b00867","article-title":"Hybrid antibiotic overcomes resistance in P. aeruginosa by enhancing outer membrane penetration and reducing efflux","volume":"59","author":"Gorityala","year":"2016","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0185","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201700029","article-title":"Synthesis and Evaluation of Thiazolidine Amide and N-Thiazolyl Amide Fluoroquinolone Derivatives","volume":"350","author":"Garza","year":"2017","journal-title":"Arch Pharm."},{"key":"10.1016\/j.bmc.2019.05.038_b0190","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00044-009-9228-2","article-title":"Synthesis and antimicrobial study of fluoroquinolone-based 4-thiazolidinones","volume":"19","author":"Patel","year":"2010","journal-title":"Med Chem Res."},{"key":"10.1016\/j.bmc.2019.05.038_b0195","first-page":"379","article-title":"Structure-activity relationships in quinolone antibacterials: design, synthesis and biological activities of novel isothiazoloquinolones","volume":"14","author":"Chu","year":"1988","journal-title":"Drugs Exp Clin Res."},{"key":"10.1016\/j.bmc.2019.05.038_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/14756366.2011.611943","article-title":"Synthesis and biological evaluation of novel benzothiazole clubbed fluoroquinolone derivatives","volume":"28","author":"Sharma","year":"2013","journal-title":"J Enzyme Inhib Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0205","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejmech.2013.06.045","article-title":"Microwave assisted synthesis of some hybrid molecules derived from norfloxacin and investigation of their biological activities","volume":"67","author":"Mentese","year":"2013","journal-title":"Euro J Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0210","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejmech.2012.11.040","article-title":"Synthesis and in vitro activity of 1, 2, 4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria","volume":"60","author":"Plech","year":"2013","journal-title":"Euro J Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0215","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejmech.2015.04.058","article-title":"Search for factors affecting antibacterial activity and toxicity of 1, 2, 4-triazole-ciprofloxacin hybrids","volume":"97","author":"Plech","year":"2015","journal-title":"Euro J Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0220","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.3390\/molecules20046254","article-title":"Determination of the primary molecular target of 1, 2, 4-triazole-ciprofloxacin hybrids","volume":"20","author":"Plech","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2019.05.038_b0225","first-page":"1463","article-title":"Synthesis of ciprofloxacin-conjugated poly (L-lactic acid) polymer for nanofiber fabrication and antibacterial evaluation","volume":"9","author":"Parwe","year":"2014","journal-title":"Intern J Nanomedicine."},{"key":"10.1016\/j.bmc.2019.05.038_b0230","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1016\/j.bmc.2014.05.067","article-title":"Synthesis and antibacterial activity of catecholate\u2013ciprofloxacin conjugates","volume":"22","author":"Fardeau","year":"2014","journal-title":"Bioorg Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0235","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejmech.2014.04.037","article-title":"Design, synthesis, and evaluation of novel fluoroquinolone\u2013flavonoid hybrids as potent antibiotics against drug-resistant microorganisms","volume":"80","author":"Xiao","year":"2014","journal-title":"Euro J Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0240","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s11095-013-1250-x","article-title":"Pharmacological characterization of 7-(4-(piperazin-1-yl)) ciprofloxacin derivatives: antibacterial activity, cellular accumulation, susceptibility to efflux transporters, and intracellular activity","volume":"31","author":"Marquez","year":"2014","journal-title":"Pharm Res."},{"key":"10.1016\/j.bmc.2019.05.038_b0245","doi-asserted-by":"crossref","unstructured":"Patel MM, Patel LJ, Design, synthesis, molecular docking, and antibacterial evaluation of some novel flouroquinolone derivatives as potent antibacterial agent, Sci World J. 2014; 2014.","DOI":"10.1155\/2014\/897187"},{"key":"10.1016\/j.bmc.2019.05.038_b0250","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.bmcl.2014.01.065","article-title":"Synthesis and antibacterial evaluation of amino acid\u2013antibiotic conjugates","volume":"24","author":"Ibrahim","year":"2014","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bmc.2019.05.038_b0255","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/BF00758634","article-title":"Synthesis and antibacterial properties of amino acid derivatives of oxolinic acid","volume":"21","author":"Leonova","year":"1987","journal-title":"Pharm Chem J."},{"key":"10.1016\/j.bmc.2019.05.038_b0260","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.bmcl.2016.03.062","article-title":"Synthesis and molecular modeling of antimicrobial active fluoroquinolone\u2013pyrazine conjugates with amino acid linkers","volume":"26","author":"Panda","year":"2016","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bmc.2019.05.038_b0265","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/cbdd.12395","article-title":"Design, Synthesis, Antibacterial Evaluation and Docking Study of Novel 2-Hydroxy-3-(nitroimidazolyl)-propyl-derived Quinolone","volume":"85","author":"Li","year":"2015","journal-title":"Chem Biol Drug Des."},{"key":"10.1016\/j.bmc.2019.05.038_b0270","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1099\/00222615-44-5-320","article-title":"Quinolones: structure-activity relationships and future predictions","volume":"44","author":"Tillotson","year":"1996","journal-title":"J Med Microbiol."},{"key":"10.1016\/j.bmc.2019.05.038_b0275","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1016\/j.bmcl.2015.07.010","article-title":"Synthesis of ciprofloxacin dimers for evaluation of bacterial permeability in atypical chemical space","volume":"25","author":"Ross","year":"2015","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bmc.2019.05.038_b0280","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.bmcl.2016.01.012","article-title":"Anionic fluoroquinolones as antibacterials against biofilm-producing Pseudomonas aeruginosa","volume":"26","author":"Long","year":"2016","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bmc.2019.05.038_b0285","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3390\/molecules22071171","article-title":"Synthesis and in vitro antimycobacterial and antibacterial activity of 8-OMe ciprofloxacin-hydrozone\/azole hybrids","volume":"22","author":"Xu","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2019.05.038_b0290","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/1570180814666170823163540","article-title":"Novel Azole-Functionalited Flouroquinolone Hybrids: Design, Conventional and Microwave Irradiated Synthesis, Evaluation as Antibacterial and Antioxidant Agents","volume":"15","author":"Mentese","year":"2018","journal-title":"Lett Drug Des Discov."},{"key":"10.1016\/j.bmc.2019.05.038_b0295","unstructured":"Gao Y, Na LX, Xu Z, Zhang S, Wang AP, L\u00fc K, Guo HY, Liu ML, Design, Synthesis and Antibacterial Evaluation of 1\u2010[(1R, 2S)\u20102\u2010Fluorocyclopropyl] ciprofloxacin\u20101, 2, 4\u2010triazole\u20105 (4H)\u2010thione Hybrids, Chem Biodivers. 2018; e1800261."},{"key":"10.1016\/j.bmc.2019.05.038_b0300","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jor.1100160417","article-title":"Effect of ciprofloxacin on the proliferation of osteoblast-like MG-63 human osteosarcoma cells in vitro","volume":"16","author":"Miclau","year":"1998","journal-title":"J Orthop Res."},{"key":"10.1016\/j.bmc.2019.05.038_b0305","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0022-3565(25)23666-7","article-title":"In vitro effects of ciprofloxacin and pefloxacin on growth of normal human hematopoietic progenitor cells and on leukemic cell lines","volume":"248","author":"Somekh","year":"1989","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1016\/j.bmc.2019.05.038_b0310","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.bjc.6600079","article-title":"Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells","volume":"86","author":"Herold","year":"2002","journal-title":"Br J Cancer."},{"key":"10.1016\/j.bmc.2019.05.038_b0315","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ejmech.2018.03.026","article-title":"Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity","volume":"150","author":"Kassab","year":"2018","journal-title":"Euro J Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0320","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/cbdd.12503","article-title":"Novel glycoconjugate of 8-fluoro norfloxacin derivatives as gentamicin-resistant Staphylococcus aureus inhibitors: synthesis and molecular modelling studies","volume":"86","author":"Azad","year":"2015","journal-title":"Chem Biol Drug Des."},{"key":"10.1016\/j.bmc.2019.05.038_b0325","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cclet.2014.09.017","article-title":"Synthesis and antibacterial activity of novel [1, 2, 4] triazolo [3, 4-h][1, 8] naphthyridine-7-carboxylic acid derivatives","volume":"26","author":"Gao","year":"2015","journal-title":"Chin Chem Lett."},{"key":"10.1016\/j.bmc.2019.05.038_b0330","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3390\/molecules22050841","article-title":"Synthesis of 1, 2, 3-Triazolo [4, 5-h] quinolone Derivatives with Novel Anti-Microbial Properties against Metronidazole Resistant Helicobacter pylori","volume":"22","author":"Abu-Sini","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2019.05.038_b0335","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s00044-011-9692-3","article-title":"Synthesis and antibacterial activity of novel 7-haloanilino-8-nitrofluoroquinolone derivatives","volume":"21","author":"Al-Hiari","year":"2012","journal-title":"Med Chem Res."},{"key":"10.1016\/j.bmc.2019.05.038_b0340","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/cmdc.201700426","article-title":"Synthesis and microbiological evaluation of novel tetracyclic fluoroquinolones","volume":"12","author":"Wagman","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2019.05.038_b0345","first-page":"636w","article-title":"Design, Synthesis and Docking Studies of Some Novel Fluoroquinolone Compounds with Antibacterial Activity","volume":"665","author":"Pintilie","year":"2018","journal-title":"Synthesis"},{"key":"10.1016\/j.bmc.2019.05.038_b0350","unstructured":"PC Spartan 2.0. Irvine CWI."},{"key":"10.1016\/j.bmc.2019.05.038_b0355","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ejmech.2017.11.090","article-title":"Synthesis and in vitro evaluation of novel substituted isatin-propylene-1H-1, 2, 3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities","volume":"143","author":"Yan","year":"2018","journal-title":"Euro J Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0360","first-page":"274","article-title":"Synthesis, anti-HIV and antitubercular activities of isatin derivatives","volume":"61","author":"Sriram","year":"2006","journal-title":"Inter J Pharm Sci."},{"key":"10.1016\/j.bmc.2019.05.038_b0365","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/jhet.3032","article-title":"Design, Synthesis and In Vitro Anti-mycobacterial Activity of Propylene-1H-1, 2, 3-triazole-4-methylene-tethered Isatin-moxifloxacin Hybrids","volume":"55","author":"Hu","year":"2018","journal-title":"J Heterocycl Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0370","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0378-5173(82)90032-1","article-title":"Physicochemical properties of the fluoroquinolone antimicrobials. II. Acid ionization constants and their relationship to structure","volume":"83","author":"Ross","year":"1992","journal-title":"Int J Pharm."},{"key":"10.1016\/j.bmc.2019.05.038_b0375","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/jps.2600791116","article-title":"Protonation equilibria of quinolone antibacterials","volume":"79","author":"Tak\u00e1cs-Nov\u00e1k","year":"1990","journal-title":"J Pharm Sci."},{"key":"10.1016\/j.bmc.2019.05.038_b0380","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1134\/S1070363215100230","article-title":"Synthesis and molecular structure of moxifloxacin drug with metal ions as a model drug against some kinds of bacteria and fungi","volume":"85","author":"El-Megharbel","year":"2015","journal-title":"Russ J Gen Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0385","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/molecules22060957","article-title":"Synthesis and Evaluation of Antimicrobial Activity of [R4W4K]-Levofloxacin and [R4W4K]-Levofloxacin-Q Conjugates","volume":"22","author":"Riahifard","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2019.05.038_b0390","first-page":"587","article-title":"Fluoroquinolone antibacterials: a review on chemistry, microbiology and therapeutic prospects","volume":"66","author":"Sharma","year":"2009","journal-title":"Acta Pol Pharm."},{"key":"10.1016\/j.bmc.2019.05.038_b0395","first-page":"1702","article-title":"Norfloxacin: A therapeutic review","volume":"6","author":"Sharma","year":"2008","journal-title":"Int J Chem Sci."},{"key":"10.1016\/j.bmc.2019.05.038_b0400","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2125.2006.02700.x","article-title":"An update on the first decade of the European centralized procedure: how many innovative drugs?","volume":"62","author":"Motola","year":"2006","journal-title":"Bri J Clin Pharmacol."},{"key":"10.1016\/j.bmc.2019.05.038_b0405","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1016\/j.bmc.2009.06.053","article-title":"7-((4-Substituted) piperazin-1-yl) derivatives of ciprofloxacin: synthesis and in vitro biological evaluation as potential antitumor agents","volume":"17","author":"Az\u00e9ma","year":"2009","journal-title":"Bioorg Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0410","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1016\/j.bmc.2010.10.039","article-title":"Novel lipophilic 7H-pyrido [1, 2, 3-de]-1, 4-benzoxazine-6-carboxylic acid derivatives as potential antitumor agents: Improved synthesis and in vitro evaluation","volume":"18","author":"Korolyov","year":"2010","journal-title":"Bioorg Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0415","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejmech.2004.09.006","article-title":"Synthetic chalcones as potential anti-inflammatory and cancer chemopreventive agents","volume":"40","author":"Won","year":"2005","journal-title":"Euro J Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0420","doi-asserted-by":"crossref","DOI":"10.1124\/mol.105.021311","article-title":"A Boronic-Chalcone Derivative Exhibits Potent Anti-Cancer Activity through Inhibition of the Proteasome","author":"Achanta","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bmc.2019.05.038_b0425","first-page":"42","article-title":"The development of chalcones as promising anticancer agents","volume":"10","author":"Ducki","year":"2007","journal-title":"IDrugs."},{"key":"10.1016\/j.bmc.2019.05.038_b0430","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1016\/j.bmcl.2006.08.065","article-title":"Effects of \u03b1-substitutions on structure and biological activity of anticancer chalcones","volume":"16","author":"Lawrence","year":"2006","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bmc.2019.05.038_b0435","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0304-3835(95)03945-S","article-title":"Anticancer and antioxidant activity of synthetic chalcones and related compounds","volume":"97","author":"Anto","year":"1995","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bmc.2019.05.038_b0440","first-page":"166","article-title":"Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs","volume":"3","author":"Kim","year":"2011","journal-title":"Am J Transl Res."},{"key":"10.1016\/j.bmc.2019.05.038_b0445","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.bmc.2010.12.017","article-title":"Syntheses, structures and antibiotic activities of LpxC inhibitors based on the diacetylene scaffold","volume":"19","author":"Liang","year":"2011","journal-title":"Bioorg Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0450","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.imbio.2017.10.008","article-title":"Immunobiological efficacy and immunotoxicity of novel synthetically prepared fluoroquinolone ethyl 6-fluoro-8-nitro-4-oxo-1, 4-dihydroquinoline-3-carboxylate","volume":"223","author":"Jantov\u00e1","year":"2018","journal-title":"Immunobiol."},{"key":"10.1016\/j.bmc.2019.05.038_b0455","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ejmech.2008.02.031","article-title":"Synthesis and antimycobacterial activities of novel 6-nitroquinolone-3-carboxylic acids","volume":"44","author":"Senthilkumar","year":"2009","journal-title":"Euro J Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0460","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0223-5234(03)00151-X","article-title":"Synthesis of 6-fluoro-1, 4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives as potential antimicrobial agents","volume":"38","author":"Rameshkumar","year":"2003","journal-title":"Euro J Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0465","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1016\/S0960-894X(99)00537-5","article-title":"Synthesis and anti-HIV activity of arylpiperazinyl fluoroquinolones: a new class of anti-HIV agents","volume":"9","author":"Hagihara","year":"1999","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bmc.2019.05.038_b0470","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2174\/138955711793564051","article-title":"Recent advances and future perspectives of triazole analogs as promising antiviral agents","volume":"11","author":"Kharb","year":"2011","journal-title":"Mini-Rev Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0475","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1086\/321846","article-title":"Quinolone molecular structure-activity relationships: what we have learned about improving antimicrobial activity","volume":"33","author":"Peterson","year":"2001","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.bmc.2019.05.038_b0480","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/jac\/33.4.685","article-title":"and structure-side-effect relationships for the quinolone antibacterials","volume":"33","author":"Domagala JMJJoAC, Structure-activity,","year":"1994","journal-title":"J Antimicrob Chemoth."},{"key":"10.1016\/j.bmc.2019.05.038_b0485","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0968-0896(96)83749-7","article-title":"Using SAR and QSAR analysis to model the activity and structure of the quinolone-DNA complex","volume":"4","author":"Llorente","year":"1996","journal-title":"Bioorg Med Chem."},{"key":"10.1016\/j.bmc.2019.05.038_b0490","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1248\/cpb.44.1074","volume":"44","author":"Yoshida","year":"1996","journal-title":"Chem Pharm Bull."},{"key":"10.1016\/j.bmc.2019.05.038_b0495","unstructured":"Ledoussal B, Almstead J, Flaim C, Novel fluoroquinolone, structure-activity, and design of new potent and safe agents, Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1999."},{"key":"10.1016\/j.bmc.2019.05.038_b0500","doi-asserted-by":"crossref","unstructured":"Cecchetti V, Fravolini A, Lorenzini MC, Tabarrini O, Terni P, Xin TJJomc, Studies on 6-aminoquinolones: synthesis and antibacterial evaluation of 6-amino-8-methylquinolones, J Med Chem. 996; 39: 436-445.","DOI":"10.1021\/jm950558v"}],"updated-by":[{"DOI":"10.1016\/j.bmc.2019.115072","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000}}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619306613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619306613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:02:29Z","timestamp":1760835749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089619306613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":100,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0968089619306613"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2019.05.038","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoroquinolones structural and medicinal developments (2013\u20132018): Where are we now?","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2019.05.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}